| Compugen Announces Positive Therapeutic Effects of Relaxin Receptor Peptide Ligand in Pulmonary Fibrosis Animal Model (Business Wire via Yahoo! Finance) |
|
|
TEL-AVIV, Israel----Compugen announced today that CGEN-25009, a novel peptide that previously demonstrated the ability to activate the Relaxin receptor LGR7 in cell based assays, has shown positive therapeutic effects in an animal model of pulmonary fibrosis. |